Akèy › Maladi atè koronè › Texas
Etid klinik pou Maladi atè koronè nan Texas
23 etid pou Maladi atè koronè ap chèche patisipan nan sit nan Texas.
Vil nan Texas
Tèks ofisyèl etid la (Anglè)
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
- Baylor Scott & White The Heart Hospital, Plano
Ap rekrite
Laj 18 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT07296744Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- PharmaTex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Inc., Amarillo
- Austin Heart, Austin
- ak 8 plis
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06909565A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- PharmaTex Research, LLC, Amarillo
- Pulse Care Heart and Vascular, Carrollton
- DM Clinical Research - Dallas, Tomball
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07521007Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Cussimanio Research Group LLC, Austin
- Research Management, Inc., Austin
- MW Clinical Research Center, Beaumont
- ak 22 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961Product Surveillance Registry
- Austin
- Dallas
- Fort Worth
- ak 6 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276Hyperpolarized 13C Pyruvate-MRI and FDG-PET in a Single Exam for the Prognosis of Ischemic Cardiomyopathy
- University of Texas Southwestern Medical Center, Dallas
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 20 a 80 · Tout sèks · Mizajou Sep 14, 2026 · NCT06814587Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability
- University of Texas Southwestern Medical Center, Dallas
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 20 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT06047028Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
- Baylor Scott & White Research Institute, Plano
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 11, 2026 · NCT07048808REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
- Baylor Scott and White, Dallas
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06399705REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
- Baylor Scott and White, Dallas
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06399692A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
- Clinical Study Center, DeSoto
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 2, 2026 · NCT06164730Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
- University of Texas Southwestern Medical Center, Dallas
- VA Dallas Medical Center, Dallas
- Baylor Heart and Vascular Hospital, Dallas
- ak 3 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 19, 2026 · NCT02061436Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
- Baylor Scott & White The Heart Hospital - Dallas, Dallas
- Ascension Texas Cardiovascular, Kyle
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06779630Virtue® SAB in the Treatment of Coronary ISR Trial
- Ascension Seton Hays, Kyle
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT07045194Prevail Global Study
- Baylor Heart & Vascular Hospital, Dallas
- HCA Houston Medical Center, Houston
- The Heart Hospital Baylor Plano, Plano
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 24, 2026 · NCT06535854The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Apr 22, 2026 · NCT05618353Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- Baylor Scott & White Research Institute, Dallas
- The University of Texas Medical Health Branch at Galveston, Galveston
- Baylor College of Medicine, Houston
- ak 1 plis
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Apr 1, 2026 · NCT04124120Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT02915198Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT04982419MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- Baylor Scott & White The Heart Hospital - Plano, Plano
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2025 · NCT06271590South Asians and Coronary Plaque Registry
- University of Texas Southwestern Medical Center, Dallas
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2025 · NCT05367297Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
- HCA Houston Healthcare Medical Center, Houston
- Baylor Scott & White Plano, Plano
- Baylor Scott & White Round Rock, Round Rock
Ap rekrite
Tout laj · Tout sèks · Mizajou Jul 24, 2025 · NCT04634240MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- Baylor Scott and White Heart and Vascular Hospital, Dallas
- Baylor Scott & White - The Heart Hospital - Plano, Plano
Ap rekrite
Laj 18 a 110 · Tout sèks · Mizajou Feb 25, 2025 · NCT05908331Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.